MitoQ, surpassing the effects of standard ubiquinone, protects from bleomycin-induced pulmonary fibrosis and reduces TGF-β1-induced oxidative stress-associated pro-fibrotic molecules upregulation. The gene discussed is TGFB1; the disease is pulmonary fibrosis.